key: cord-0761602-nx9gkgxb
authors: Alagarsamy, Subburaj; Mehrolia, Sangeeta; Pushparaj, Ushanandini; Jeevananda, S
title: Explaining the intention to uptake COVID-19 vaccination using the Behavioral and Social Drivers of Vaccination (BeSD) model
date: 2022-01-05
journal: Vaccine X
DOI: 10.1016/j.jvacx.2021.100140
sha: 581b5f5b0c760e7807f2a67de765db7e35e04f93
doc_id: 761602
cord_uid: nx9gkgxb

BACKGROUND: The World Health Organization (WHO) has proposed a tool to measure behavioral and social drivers (BeSD) of vaccination uptake intentions of people across all countries. This study tests BeSD model to predict people’s intentions to uptake COVID-19 vaccination in rural India. METHODS: An online cross-sectional survey was developed for the purpose based on the components of the BeSD model, i.e., confidence, motivation, and behavioral intention. A convenient sampling technique was used to collect samples, amounting to a total of 625, from rural Bengaluru, in the Karnataka state of India. Structural equation modelling (SEM) was applied to examine the proposed model. All respondents for the survey were in the age category of 18-68 years with a mean age of 35 years. Findings The results showed that 85% of COVID-19 vaccine uptake intentions can directly or indirectly be attributed to the government’s vaccine communication strategy, perceived threats about the vaccine, and their trust in the healthcare sector. The dimensions of the vaccine acceptance scale (motivation factors) act as a mediator between these factors and COVID-19 vaccination uptake (the behavioral factor). CONCLUSION: The study demonstrates that the BeSD framework is an efficient model for predicting the COVID-19 vaccination uptake in India.

India is home to the world's second largest population, amounting to 1.4 billion people. Needless to say, containing the pandemic in the country is a mammoth task. The [1] . However, the government is tasked with addressing a major concern and that is vaccination hesitancy, or in other words, hesitancy on the part of the people to voluntary take the vaccine. The hesitancy can be attributed to several reasons, primarily, lack of awareness and trust in the safety of the vaccines and misinformation about COVID-19 vaccine and its technological approach. Due to poor knowledge between populations about types of vaccine, its dosing recommendations, and the poor commitment to hygiene practices, the national and international health organizations are organizing campaigns to increase the public awareness level about the COVID-19 vaccines [2] . The vaccination program campaigns include advertisements on social media and television to increase the population's awareness of COVID-19 vaccines and show the importance of public vaccination to limit the spread of coronavirus infections [2, 3] .The initial lack of trust can be attributed to the lack of vaccine trials. Vaccine hesitancy and refusal to accept vaccines are common in India, even for routine immunization [4] . As a result, vaccine hesitancy linked to COVID-19 vaccines is nothing new or surprising. Even before the COVID-19 pandemic, the overall vaccination hesitancy to routine childhood vaccines in India was on the rise [5] . When the Measles-Rubella vaccination was first offered in India in 2016, there were several cases of hesitancy [6, 7] . When the COVID-19 vaccination campaign began in India on January 16, 2021, there was considerable skepticism among health care providers, who were the target group to be covered at the time [4] . At the time, COVID 19's first wave had just ended, and the second had not yet begun. A prominent South Indian film actor and comedian who strongly supported the state government's COVID 19 vaccination effort was vaccinated in a public event. The following day, on April 17, he suffered a sudden cardiac arrest and died from causes unrelated to the vaccination.

His death, however, sparked a flurry of conspiracy claims about COVID 19 vaccine-related deaths.

This exacerbated the vaccine hesitation in Indian, mainly in south India [4] . While the vaccine uptake intention amongst Indians is gradually increasing, the hesitancy still remains a cause of concern in the rural areas.

In a vaccine market that continues to see a demand-supply mismatch, the revised vaccine procurement process builds in a skew against smaller hospitals in cities and towns in comparison to their bigger counterparts in simply getting access to the shots, and a more disconcerting urbanrural divide in terms of where healthcare facilities are vis-à-vis the already-established supplychain map [8, 9] . In the guidelines for the "Liberalised and Accelerated Phase 3 Strategy of Covid-19 Vaccination", the Centre mandated prior online registration on the CoWin portal for the 18-44 years age group. Mandatory online registration introduces a skew in favor of urban centres, given that a little over half of India's population has access to broadband Internet, while rural teledensity is under 60%-with states including Bihar, Uttar Pradesh, Chhattisgarh, Jharkhand, and Madhya Pradesh having among the country's lowest teledensity [8, 10] . These are the main reasons which affect the availability and accessibility of vaccination services in rural areas in India. However, no matter how convincing and irrefutable the science and the data about the COVID-19 vaccines are, misinformation spreads so easily and quickly-that it has become a significant barrier stopping India from reaching higher levels of vaccination. The main myth is that COVID-19vaccines were not rigorously tested, which is why they have only emergency authorization approval by country.

The second common myth was that the technology used to create the COVID-19vaccines was too new to be safe. The following common myth is that getting the COVID-19 vaccine gives COVID-19 [11] . The aim of the study is to highlight the reasons for the hesitancy in rural areas. Our findings will help decision-makers address this hesitancy, and consequently improve vaccination intention in these areas.

With no "one-size-fits-all" solution to vaccine hesitancy and vaccine acceptance, there is need for contextualized and curated approaches. The WHO working group experts have developed the Behavioural And Social Drivers (BeSD) vaccination model, which emphasizes "motivation" as the vanguard of human psychology during a vaccination drive [12] . Country like Israel have successfully inoculated a significant percentage of citizens using incentives and motivation [13] .

Unfortunately, in India, misinformation, and misplaced beliefs have led to fears about the potentially harmful effects of vaccines [14] . In light of this situation, this study aims to use the "BeSD" vaccination model (figure 1) as a theoretical stance to map the relationship between vaccination confidence, motivation, behaviour and the practical issues that affect vaccine uptake among rural Indians.

BeSD of vaccination uptake model consists of three stages, i.e., confidence, motivation and behavior [12, 15] . The motivation stage is explained from two perspectives, i.e., vaccination demand and hesitancy among people. Demand is a complex concept and its estimations are based on human interaction with the system, government structure and dynamics, and so it best serves as an external variable [16] . Hesitancy is another means to explain the motivation stage. It refers "Vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite availability of vaccine services. Vaccine hesitancy is complex and context specific, varying across time, place and vaccines. It is influenced by factors such as complacency, convenience and confidence" [17] .

Vaccine hesitancy manifests itself in delay in acceptance or complete refusal to get vaccinated [16] . Hence, this study measures motivation towards vaccine uptake on a Vaccine Acceptance Scale and behavior based on the vaccine intake intention. The motivation stage is always built on the confidence people have towards an initiative [18] . In this study, people's confidence in vaccine 

While vaccinations have been successfully developed in several countries, the major success depends on the willingness of the people to actually take the jab [19, 20] . "The Drivers of COVID-19 vaccination Acceptance Scale (DrVac-COVID19S)" appears to be a wellconstructed and validated instrument to measure an individual's intention, attitude, and thoughts to take the COVID-19 vaccine [21, 22] . This scale was developed and adapted from a well-established scale, the MoVac-Flu Scale-Motors of Influenza Vaccination Acceptance Scale, which was developed to assess influenza vaccination acceptance [23, 24] . Like the MoVac-Flu Scale, the DrVac COVID-19S scale is also developed on the Cognitive Model of Empowerment assuming that intrinsic motivation is required to engage in purposeful behavior.

Value: Purposeful behavior or task is assessed based on a person's standards and concern towards performing the behavior [21] .

Impact: A person's awareness and knowledge about the benefits of the action to undertake can ensure a successful launch of any new initiative. If people feel that their actions would contribute to the general welfare of the society, they are more likely to adopt a change in behavior [14, 25] .

Autonomy: Studies have explained autonomy as an individual's control over their decision, independence, and freedom to schedule their tasks at any point in time [19, 23] . Many studies represent this variable as choice. If autonomy is high, then individuals are more empowered, and acceptance is high [22, 26] .

Knowledge: Knowledge about a new initiative or goal increases a person's confidence and selfesteem, which further increases their trust in the initiative and benefits the organization.

Accordingly, when people have more knowledge about the vaccine, the different types of vaccines available, and their benefits and their side-effects, they are more likely to make an informed choice [14, 27] .

Vaccine hesitancy is one of the top 10 threats to global health [28] and anti-vaccine or antivaccination movements become common amidst any pandemic situation [29] and antivaccination campaigns have gathered more stream than ever due to the social media and encourage vaccine hesitancy. The reasons for vaccine denial vary from one region to another.

However, a common cause remains the misinformation caused on the Internet which has severally impacted vaccination drives worldwide [30] . The constant stream of misinformation has caused fear among the general populations with regards to the side-effects and the aftereffects of taking the COVID-19 vaccination [26] . Threats negatively influence peoples' belief systems; push them to question their own knowledge about the disease; induce fear; and affect autonomous decision-taking in the context of the vaccine [31] . These studies show that subjective perceptions of the threat posed by the COVID-19 vaccine will negatively influence its acceptance and uptake intentions [32] .

It is important for policymakers and administrators to build trust about the vaccine amongst the people to successfully tackle the pandemic and prevent further loss of life. For this, trust has to be studied from all perspectives, especially in the context of the healthcare industry [33, 34] including trust in the vaccine brand and effectiveness, the health care providers [35] , and the government and healthcare departments [34, 36] . Existing studies show that intention to take vaccines is highly associated with people's trust in the government and their perceived vulnerability to the disease [37] . Trust is also governed by other factors such as the country of origin [38] .

Evidence-based health communication strategies are required to address vaccination hesitancy and successfully build vaccine trust [39] . The government has to consider appropriate communication strategies to counter misinformation and reduce mistrust, xenophobia, misinformation exposure and endorsement [40] , along with other strategies to build awareness, educate people and build an environment of trust in order to induce people to get vaccinated. . Timely and updated communication can improve confidence, which in turn, will enable people to take autonomous decisions with regards to taking the jab. Therefore, people's vaccine hesitancy can be addressed with timely available information [21, 27] . Figure 1 shows the hypothesised links in detail.

The quantitative method was used to test the hypotheses, and the cross-sectional survey method was used to collect data using the convenient sampling technique. The questionnaire was were some questions that aimed to collect the demographic details of the participants.

The questionnaire was administered in the local language, and we followed the procedures prescribed by Brislin (1986) for developing the translated version of the instrument [41] . First, two Kannada native-speaking professors translated the English version into the local language and then back-translated it into English. We administered the survey to 100 respondents and checked the initial reliability. The initial Cronbach alpha values for all research constructs are greater than 0.7 and conclude instruments internal consistency. It was added to the original sample since no items were removed from the survey based on a pilot study. Content validity describes whether an instrument is systematically and comprehensively representative of the trait it is measuring [42] . For this purpose, Community Health Workers were contacted and asked to validate the research instrument. Since community health workers play a significant role during the COVID-19 pandemic, their feedback was taken to check the relevance of the research instrument.

Ethical approval for this study was submitted and approved by the Research Conduct and Ethics Committee (CU: RCEC/37/04/21), Center for Research, CHRIST (Deemed to be University), Bengaluru-560029, India.

In cross-sectional studies, the aim is to estimate the prevalence of unknown parameter(s) from the target population using a random sample. So, an adequate sample size is needed to estimate the population prevalence with good precision. The following simple formula would calculate the adequate sample size [ ] in prevalence study [43, 44] . Where n is the sample = 2 (1 -) 2 size, Z is the statistic corresponding to confidence level (most researchers present their results with a 95% confidence interval; Z=1.96), P is expected prevalence, and d is precision (corresponding to effect size). Studies recommended selecting a precision (d) of 5% if the prevalence is between 10% and 90% [43, 44] . The pilot study results yielded that 42% of the rural respondents are agreed and strongly agreed to uptake the COVID-19 vaccine. The prevalence of COVID-19 vaccine uptake is (P) 42%. Based on the above formula, the adequate sample size =374.

In the face of the ongoing COVID-19 pandemic, online survey method has emerged as the preferred means to collect data [45] . It also works well with the respondents as they can keep their identity anonymous. Accordingly, we prepared the E-questionnaire on Survey Monkey and shared the link to the respondents through official e-mails, LinkedIn, WhatsApp, and Facebook. Conscious follow-up was done, and reminders were sent through emails and messages on social media sites.

It is not easy to calculate the response rate of an online survey because it is difficult to trace the number of people who have read the questionnaire on different social media platforms. To resolve this issue, filter questions such as age and location were used to select participants.

Only respondents above 18 years of age and from rural Bengaluru were allowed to participate.

We received 710 responses, out of which 12 were withdrawn by the participants; and 73 responses were removed from the sample based on base timeline and missing data calculations.

The final sample size comprised of 625 respondents; however, the present study sample was more than adequate.

According to the Ministry of Electronics & Information Technology, Government of India, Bengaluru Urban occupies the fifth position in the list of total vaccination uptakes in the country. It is observed that people's perception towards the vaccination is gradually improving in Bengaluru Urban. However, many people still remain hesitant to take the COVID-19 vaccination in Bengaluru Rural and this is the reason why it was chosen as a base for this research. This area also hosts a diverse population, thus, providing an adequate representation of the robust Indian population. Further, Bengaluru is the third most populous city in India, accommodating people from different socioeconomic backgrounds [46] .

The data were collected between March 2021 and June 2021, at a time when India had launched its COVID-19 vaccination drive for all people above the 18+ years' group. The study sample consisted of 625 participants in the age category of 18-68 years with a mean age of 35 years. between 75,000-99,999 and 23.2% more than INR100,000.

As the sample was large and had uneven distribution, partial least square structure equational modeling (PLS-SEM) was used for data analysis, and SmartPLS3 to test the measurement and structural models. The measurement model was measured using the indicators, reliability, internal consistency reliability, and construct validity [47] . Indicator reliability was achieved by checking the outer loading of each indicator. In all cases, it should be greater than 0.7. The internal consistency reliability was checked using Cronbach Reliability (Cronbach's α) and

Composite Reliability (CR). For both, the cut-off value should be greater than 0.7. Construct validity can be achieved by testing convergent validity and discriminant validity. Convergent validity is generally considered adequate if the average variance extracted (AVE) is greater than 0.5. Discriminant Validity can be tested using the Fornell-Larcker criterion. Figure 2 shows that all the indicators in this study met the thresholds and so were retained. CR, AVE and Cronbach's α values are presented in Table 1 . Thus, the measurement model had both convergent validity and internal consistency. Finally, the Fornell-Larcker criterion was evaluated by comparing the construct AVE values with the shared variances between the constructs [48] . The square root of AVE was higher than the inter-constructed correlations [47] , supporting the discriminant validity of the constructs, as shown in Table 1 . 

In the second step, the significance of the path coefficient (β) between the independent and dependent constructs was tested. The path coefficients are shown in Table 2 and Figure 2 . The statistical significance level at 5% (p<0.05) shows that hypotheses were accepted.

In the third step, the predictive accuracy of the model was tested using f 2 and R 2 [47] . The model's predictive accuracy was tested using effect size (f 2 ). R 2 was used to assess the level of the variance in the dependent variable predictable from the independent variables. Studies recommends the interpretations of f 2 values 0.02 as small effect; 0.15 as medium effect; and 0.35 as a large effect [49] and recommend the acceptable R 2 values as 0.190 weak; 0.333 moderate; and 0.670 substantial [47] . Table 2 explains the effect size for all hypotheses.

In the fourth step, the predictive relevance of the model (Q 2 ) was measured using the blindfolding technique. Q 2 values should ideally be larger than 0 (Q 2 >0) in order to have predictive relevance. Accordingly, all Q 2 values were larger than zero suggesting that our model has considerable predictive power (see Table 2 ).

Finally, vaccine even before it has completed the necessary trials. This itself has raised significant concerns over vaccine confidence and intention. In the face of this, it can be concluded that the government's communication strategy can be further improved to generate trust in the Indian healthcare system.

The study, like other studies, has its limitations. First, the study considers 625 rural samples from India, with samples selected through convenience sampling, and respondents participating voluntarily. Hence, the generalizability of the results is restricted. The study uses the BeSD framework as a theoretical stance. However, a few researchers have used the extended theory of planned behaviour and the health belief model to predict vaccine intention.

Future research can use different theoretical models, such as protection motivation theory, novel behavioural reasoning theory and self-determination theory to glean deeper insights.

Next, we used a cross-sectional design with no long-term follow-up. The Indian government's communication strategy is continuously evolving, providing fodder for more research. Future research can also use data triangulation techniques to reduce response bias; mixed-method research needs to be done to understand other potential variables that influence an individual's vaccine intentions.

Cumulative Coverage Report of COVID-19 Vaccination

COVID-19 patients and contacted person awareness about home quarantine instructions

Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy

Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India -a community based survey

Assessment of vaccine hesitancy among parents of children between 1 and 5 years of age at a tertiary care hospital in Chennai

Social capital, trust in health information, and acceptance of Measles-Rubella vaccination campaign in Tamil Nadu: A case-control study

Coverage of childhood vaccination among children aged 12-23 months

Facts: Making Sense of COVID-19 Vaccine Misinformation. The Brink

Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?

Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel's COVID-19 vaccination program

Using structural equation modeling to predict Indian people's attitudes and intentions towards COVID-19 vaccination

Increasing vaccine acceptance using evidence-based approaches and policies: Insights from research on behavioural and social determinants presented at the 7th Annual Vaccine Acceptance Meeting

Increasing Vaccination: Putting Psychological Science Into Action

Report of the SAGE working group on vaccine hesitancy

Addressing the vaccine confidence gap

The changing acceptance of COVID-19 vaccination in different epidemic phases in China: A longitudinal study

The COVID-19 vaccine is herenow who is willing to get it?

Measurement invariance of the drivers of covid-19 vaccination acceptance scale: Comparison between taiwanese and mainland chinese-speaking populations

Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors

Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students

Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: Development and validation of two short scales

Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: A comparative study in six European countries

COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey

Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries

Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study

World Health Organization. Ten threats to global health in 2019

A postmodern Pandora's box: Anti-vaccination misinformation on the Internet

Novel coronavirus, poor quarantine, and the risk of pandemic

A race for a better understanding of COVID-19 vaccine non-adopters

Covid-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates

Government capacity, societal trust or party preferences: what accounts for the variety of national policy responses to the COVID-19 pandemic in Europe?

You don't trust a government vaccine": Narratives of institutional trust and influenza vaccination among African American and white adults

Acceptance of the COVID-19 vaccine based on the health belief model: A populationbased survey in Hong Kong

Why have immunization efforts in Pakistan failed to achieve global standards of vaccination uptake and infectious disease control?

Perceived risk of COVID-19 pandemic: The role of public worry and trust

Rebuilding public trust: a clarified response to COVID-19 vaccine hesitancy predicament

Leveraging media and health communication strategies to overcome the COVID-19 infodemic

Global sentiments surrounding the COVID-19 pandemic on Twitter: Analysis of Twitter trends

The wording and translation of research instruments

Content and Criterion Validity Evaluation of National Public Health Performance Standards Measurement Instruments

Practical Issues in Calculating the Sample Size for Prevalence Studies

Sample size calculation in medical studies

Opinions from the epicenter: an online survey of university students in Wuhan amidst the COVID-19 outbreak11

Citizens Perceptions on Democratic Capital in Bangalore

Multivariate Data Analysis: Pearson New International Edition

Evaluating Structural Equation Models with Unobservable Variables and Measurement Error

Statistical Power Analysis for the Behavioral Sciences

Covid-19: India is at centre of global vaccine manufacturing, but opacity threatens public trust

Fake news and COVID-19: modelling the predictors of fake news sharing among social media users

Is COVID-19 Immune to Misinformation? A Brief Overview

Covid-19 vaccine communication strategy

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no conflict of interest with any commercial or other associations in connection with the submitted article.Sincerely, Subburaj Alagarsamy, Sangeeta Mehrolia, Ushanandini Pushparaj, Jeevananda S